Tech Base/Enabling Rsrch for Infect Dis Adv Tech
Abstract
Advanced technology development, demonstration, and integration of model systems required for Food and Drug Administration (FDA) approval or licensure of medical countermeasures, such as drugs, vaccines, and devices, against military health threats for which human effectiveness studies are not feasible or ethical. Research is conducted in compliance with FDA regulations and guidance. Work is managed by the United States Army Medical Research and Development Command (USAMRDC). Technologies developed in this Project are integrated with specific countermeasures under PE 0603807A (Medical Systems Advanced Development) to conduct pivotal demonstrations of effectiveness required for FDA approval. The cited work is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. All FY20 adjustments align program resources to Army Modernization Priorities in support of the National Defense Strategy. Work in this Project is performed by the USAMRDC, Fort Detrick, MD including USAMRIID (Fort Detrick, MD) and USAMRICD (Aberdeen Proving Ground, MD).
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2022
- Source ID
- MM9_0603002A_3_2040_PB_2022
Related Documents
- Root: Medical Advanced Technology
- Child Accomplishment: Advanced Technology Research on drugs and vaccines against parasitic diseases
- Child Accomplishment: Viral Disease Threats